Rebecca Kusko
Rebecca Kusko
Immuneering
Verified email at immuneering.com - Homepage
Title
Cited by
Cited by
Year
Drug repurposing from the perspective of pharmaceutical companies
Y Cha, T Erez, IJ Reynolds, D Kumar, J Ross, G Koytiger, R Kusko, ...
British journal of pharmacology 175 (2), 168-180, 2018
1252018
Integrated genomics reveals convergent transcriptomic networks underlying chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis
RL Kusko, JF Brothers, J Tedrow, K Pandit, L Huleihel, C Perdomo, G Liu, ...
American journal of respiratory and critical care medicine 194 (8), 948-960, 2016
742016
The sigma-1 receptor mediates the beneficial effects of pridopidine in a mouse model of Huntington disease
D Ryskamp, J Wu, M Geva, R Kusko, I Grossman, M Hayden, ...
Neurobiology of disease 97, 46-59, 2017
662017
Leveraging an NQO1 bioactivatable drug for tumor-selective use of poly (ADP-ribose) polymerase inhibitors
X Huang, EA Motea, ZR Moore, J Yao, Y Dong, G Chakrabarti, JA Kilgore, ...
Cancer cell 30 (6), 940-952, 2016
662016
Pridopidine activates neuroprotective pathways impaired in Huntington Disease
M Geva, R Kusko, H Soares, KD Fowler, T Birnberg, S Barash, ...
Human molecular genetics 25 (18), 3975-3987, 2016
562016
PGE2-driven expression of c-Myc and oncomiR-17-92 contributes to apoptosis resistance in NSCLC
K Krysan, R Kusko, T Grogan, J O'Hearn, KL Reckamp, TC Walser, ...
Molecular Cancer Research 12 (5), 765-774, 2014
452014
Transparency and reproducibility in artificial intelligence
B Haibe-Kains, GA Adam, A Hosny, F Khodakarami, L Waldron, B Wang, ...
Nature 586 (7829), E14-E16, 2020
342020
Premature expression of a muscle fibrosis axis in chronic HIV infection
RL Kusko, C Banerjee, KK Long, A Darcy, J Otis, P Sebastiani, S Melov, ...
Skeletal muscle 2 (1), 1-12, 2012
342012
Advanced bioinformatics rapidly identifies existing therapeutics for patients with coronavirus disease-2019 (COVID-19)
J Kim, J Zhang, Y Cha, S Kolitz, J Funt, RE Chong, S Barrett, R Kusko, ...
Journal of translational medicine 18 (1), 1-9, 2020
262020
Early pridopidine treatment improves behavioral and transcriptional deficits in YAC128 Huntington disease mice
M Garcia-Miralles, M Geva, JY Tan, NABM Yusof, Y Cha, R Kusko, LJ Tan, ...
JCI insight 2 (23), 2017
212017
A pharmacogenetic signature of high response to Copaxone in late-phase clinical-trial cohorts of multiple sclerosis
CJ Ross, F Towfic, J Shankar, D Laifenfeld, M Thoma, M Davis, B Weiner, ...
Genome medicine 9 (1), 1-15, 2017
192017
Large-scale transcriptomic analysis reveals that pridopidine reverses aberrant gene expression and activates neuroprotective pathways in the YAC128 HD mouse
R Kusko, J Dreymann, J Ross, Y Cha, R Escalante-Chong, ...
Molecular neurodegeneration 13 (1), 1-15, 2018
172018
The international MAQC Society launches to enhance reproducibility of high-throughput technologies
L Shi, R Kusko, RD Wolfinger, B Haibe-Kains, M Fischer, SA Sansone, ...
Nature biotechnology 35 (12), 1127-1128, 2017
172017
Similarities and differences between variants called with human reference genome HG19 or HG38
B Pan, R Kusko, W Xiao, Y Zheng, Z Liu, C Xiao, S Sakkiah, W Guo, ...
BMC bioinformatics 20 (2), 17-29, 2019
162019
Structural changes due to antagonist binding in ligand binding pocket of androgen receptor elucidated through molecular dynamics simulations
S Sakkiah, R Kusko, B Pan, W Guo, W Ge, W Tong, H Hong
Frontiers in pharmacology 9, 492, 2018
152018
II, Tedrow J, Pandit K, Huleihel L, Perdomo C, Liu G, Juan-Guardela B, Kass D, Zhang S, et al. Integrated genomics reveals convergent transcriptomic networks underlying chronic …
RL Kusko, JF Brothers
Am J Respir Crit Care Med 194, 948-960, 2016
102016
II, Tedrow J, Pandit K, Huleihel L, Perdomo C, et al. Integrated genomics reveals convergent transcriptomic networks underlying chronic obstructive pulmonary disease and …
RL Kusko, JF Brothers
Am J Respir Crit Care Med 194, 948-960, 2016
102016
Computational prediction models for assessing endocrine disrupting potential of chemicals
S Sakkiah, W Guo, B Pan, R Kusko, W Tong, H Hong
Journal of Environmental Science and Health, Part C 36 (4), 192-218, 2018
92018
Quantitative structure–activity relationship models for predicting inflammatory potential of metal oxide nanoparticles
Y Huang, X Li, S Xu, H Zheng, L Zhang, J Chen, H Hong, R Kusko, R Li
Environmental health perspectives 128 (6), 067010, 2020
82020
Letter to the Editor response: Nygaard et al.
F Towfic, R Kusko, B Zeskind
Biostatistics 18 (2), 197-199, 2017
52017
The system can't perform the operation now. Try again later.
Articles 1–20